Key result
Genetic polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 showed comparable genotype frequencies across South-East and East Asian populations in a systematic review of 86 studies.
Why the study?
Genetic polymorphism drives interindividual and interethnic variability in drug response, with known genotype frequency differences across major populations, prompting a systematic review of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 polymorphisms in South-East and East Asian populations.
Systematic Review
This systematic review establishes that genotype frequencies of major drug-metabolizing CYP enzymes are generally comparable across South-East and East Asian populations.
No takes yet. Share an insight, caveat, or question.
Supports unified CYP pharmacogenetic dosing across South-East and East Asian populations; confirms comparable genotype frequencies in high-quality synthesis.
Dorji et al. (2019) conducted a systematic review in Genetic polymorphisms in CYP2C9, CYP2C19, CYP2D6 and CYP3A5. Genetic polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 showed comparable genotype frequencies across South-East and East Asian populations in a systematic review of 86 studies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: